Navigation Links
Circassia Extends its Clinical-Stage Portfolio With Phase II Trials of T-Cell Vaccines Against House Dust Mite and Cat Allergies
Date:1/19/2010

l regulatory and supply chain benefits. The short peptides utilised in Circassia's vaccines are manufactured chemically, in contrast to existing allergen immunotherapies, which are purified from natural sources. Circassia's approach applies the chemistry, manufacturing and control standards associated with conventional pharmaceuticals to its allergy T-cell vaccines. This fits with changes in the European regulatory environment, where authorities are increasingly treating allergen immunotherapies as pharmaceutical products, and requiring elimination of the batch-to-batch potency variability that is an intrinsic feature of many current treatments.

About Circassia

Circassia has a highly experienced management team with a proven track record in product development and commercialisation. Having successfully completed three fundraising rounds the company is backed by a syndicate of world-class venture capital and institutional investors, including Imperial Innovations, Invesco Perpetual, Goldman Sachs and Lansdowne Partners.

    For more information please visit http://www.circassia.co.uk.

    Contacts
    Steve Harris                             Rob Budge
    CEO                                      RJB Communications
    Circassia                                Tel: +44(0)1865-760969
    Tel: +44(0)1865-784574                   Mobile: +44(0)7710-741241


SOURCE Circassia Ltd


'/>"/>
SOURCE Circassia Ltd
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Circassia Raises GBP15 Million ($25 Million) in Oversubscribed Investment Round
2. Circassia Begins Phase II Clinical Trial With Ragweed Allergy Therapy
3. Circassias Allergy Therapy Begins Phase II Clinical Trial in Asthma Patients
4. Circassia Completes Patient Recruitment for Phase II Clinical Trial of Toleromune(R) Allergy Treatment
5. Circassia Initiates Further Phase II Clinical Study of Toleromune(R) Anti-Allergy Technology
6. Circassia Achieves Successful Phase II Clinical Results With Toleromune(R) Anti-Allergy Technology
7. Cadence Pharmaceuticals Announces FDA Extends New Drug Application Review for Intravenous Acetaminophen by Three Months
8. Applied Seals North America Extends Global Network With Addition of Distributor in Europe
9. Lincare Holdings Inc. Extends Terms of Employment Agreements with Executive Officers
10. Neurosciences Institute Discovers Drug Extends Stroke Treatment Time to 24 Hours, Repairs Brain Tissue
11. FDA Extends Review Period for Daiichi Sankyo, Lilly Investigative Antiplatelet Drug, Prasugrel
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2014)... Sept. 15, 2014 /CNW/ - Health Minister Rona Ambrose ... make available for donation over $2.5 million in personal protective ... in the global response to the Ebola outbreak in ... reported a shortage of equipment in the affected countries and ... front-line workers in the affected countries. Personal ...
(Date:9/15/2014)... FRANCISCO , Sept. 15, 2014 ... studies presented at the American Society for Radiation ... its Decipher® Prostate Cancer Classifier, a genomic test ... influence treatment decisions and improve patient outcomes for ... These presentations follow a recently published study that ...
(Date:9/15/2014)... , Sept. 15, 2014  Alere Inc. (NYSE: ... in infectious disease, toxicology, cardiology and diabetes products and ... led by former CEO Ron Zwanziger , filed ... and subsequently sent a letter to Gregg J. ... of due diligence in an effort to secure financing ...
Breaking Medicine Technology:Canada offers essential protective equipment to help stop the spread of Ebola in West Africa 2Canada offers essential protective equipment to help stop the spread of Ebola in West Africa 3Two New Studies Show Decipher Genomic Prostate Cancer Test Charts Best Course of Treatment and Influences Patient Outcomes 2Two New Studies Show Decipher Genomic Prostate Cancer Test Charts Best Course of Treatment and Influences Patient Outcomes 3Alere Responds To Letter From Former Executives 2
(Date:9/15/2014)... September 15, 2014 The new North ... Sept. 15 near Raintree Dr. and Loop 101, after ... Lane and dignitaries from the healthcare community on Friday, ... seven operating rooms, four gastro-intestinal procedure rooms, and a ... it the largest surgery center in the state of ...
(Date:9/15/2014)... New York (PRWEB) September 15, 2014 ... Bard, Inc. continue to move forward in the federal ... District of West Virginia, Bernstein Liebhard LLP reports. According ... a Final Order on September 10th that provides for ... Order notes that none of the affected plaintiffs has ...
(Date:9/15/2014)... one out of every 40 individuals in the United States ... atrophy (SMA), a neurodegenerative disease that causes muscles to weaken ... made a recent breakthrough with the development of a new ... the disease. In April, a patent was filed for the ... is using to fight SMA is to ,repress the repressor," ...
(Date:9/15/2014)... This year, Avenidas Village ... To mark the special occasion, Avenidas Village would like ... and helping it to get started seven years ago. ... community for seniors. Members of Avenidas Village maintain their ... their own homes. They are able to have an ...
(Date:9/15/2014)... Sept. 15, 2014 (HealthDay News) -- Births of multiple ... and death than singleton births, researchers report. The ... in vitro fertilization (IVF) could ease some of that ... have increased in tandem with births to older mothers ... from the University of New South Wales, Australia. ...
Breaking Medicine News(10 mins):Health News:New North Valley Surgery Center Is Arizona’s Largest Outpatient Facility 2Health News:New North Valley Surgery Center Is Arizona’s Largest Outpatient Facility 3Health News:New North Valley Surgery Center Is Arizona’s Largest Outpatient Facility 4Health News:C.R. Bard Transvaginal Mesh Lawsuits Move Forward, With Issuance of New Order in Federal Multidistrict Litigation, Bernstein Liebhard LLP Reports 2Health News:C.R. Bard Transvaginal Mesh Lawsuits Move Forward, With Issuance of New Order in Federal Multidistrict Litigation, Bernstein Liebhard LLP Reports 3Health News:Researcher develops and proves effectiveness of new drug for spinal muscular atrophy 2Health News:Avenidas Village Celebrates Anniversary 2Health News:Study Ties Multiple Births to Higher Costs, Complications 2Health News:Study Ties Multiple Births to Higher Costs, Complications 3
... are using the sun to power an autoclave that sterilizes ... developing countries. The student,s used Capteur Soleil, a ... capture the energy of the sun in places where electricity ... get. In attaching an insulated box containing the autoclave, the ...
... 2011 The National Academy of Sciences today elected ... UT Southwestern Medical Center, to membership, representing one of ... With Dr. Parada,s election, UT Southwestern now has 19 ... than all other academic medical centers in Texas combined. ...
... Amanda Gardner HealthDay Reporter , TUESDAY, May 3 ... prior to deployment or who,ve been injured during combat are ... return home. The PTSD tends to be worse with ... issue of the Archives of General Psychiatry . ...
... screening rates increased for Medicare beneficiaries when coverage ... still exist, according to researchers at The University ... "Despite the expansion of Medicare coverage for ... groups we examined," said Arica White, Ph.D., M.P.H., ...
... Researchers from Boston University School of Medicine and Boston Medical ... 1,000, or 100 per 100,000, could reduce hospital readmission costs ... Patient Protection and Affordable Care Act (ACA) target. These findings ... a primary care think tank. Growth of family physicians ...
... anticipated to bring more extreme weather phenomena such as heat ... An analysis led by researchers at the Johns Hopkins Bloomberg ... could experience between 166 and 2,217 excess deaths per year ... for the final decades of the 21st century. The study ...
Cached Medicine News:Health News:Rice U. parlays sun's saving grace into autoclave 2Health News:UT Southwestern's Luis Parada elected to National Academy of Sciences 2Health News:UT Southwestern's Luis Parada elected to National Academy of Sciences 3Health News:Military Personnel With Mental Woes Before Deployment at Higher PTSD Risk 2Health News:Colorectal cancer screening rates on rise among Medicare beneficiaries due to expansion of coverage 2Health News:Researchers find increasing the number of family physicians reduces hospital readmissions 2Health News:Climate change analysis predicts increased fatalities from heat waves 2
... The Equalizer With 384 Well Plate Capability ... revolutionary features of the original Equalizerexpandable and equal ... components, and in-lab calibration capabilities. In addition, this ... down to 4.5mm for loading and accessing many ...
... Exp Expandable Tip System A ... System allows you to perform multi-sample transfers between ... pull of a knob, tip spacing can be ... microcentrifuge tubes) or 96 well plates. Ergonomic ...
... Quickly transfer samples from 96-well ... gels. Accurately deliver 0.5-5 μl. ... in six minutes or less. ... 377 and other gels with ...
... Expandable, Multichannel Pipettor The Equalizer ... productivity with an industry breakthroughequal tip spacings ... a slide rod. This innovation allows the ... vessels with different configurations. Adjustable and ...
Medicine Products: